Covista Inc. (ATGE) Form 8-K — Oct 29, 2026
Covista (NYSE: CVSA) reported Q1 FY2027 revenue of $511.5 million, up 10.7% year over year, with GAAP diluted EPS of $1.95 and adjusted EPS of $2.19, up 25.1%. Total enrollment of 104,713 grew 7.6%, marking the 13th straight quarter of growth. The company raised its FY2027 guidance, lifting revenue to $2,060-$2,095 million and adjusted EPS to $9.00-$9.20, up from prior ranges of $2,050-$2,090 million and $8.90-$9.15. Adjusted EBITDA rose 17.1% to $131.2 million with a 25.6% margin.
Key figures
- Eps
- 1.95
- Revenue
- 511500000
- Guidance
- FY2027 revenue raised to $2,060M-$2,095M (5.5-7% growth); adjusted EPS raised to $9.00-$9.20 (9-11.5% growth)
- Net Income
- 67400000
- Total Debt
- 510000000
- Revenue Yoy
- 10.7%
- Total Assets
- 2928273000
- Cash Position
- 222223000
- Shares Outstanding
- 33951000
- Adjusted eps
- 2.19
- Net leverage
- 0.5x
- Enrollment yoy
- 7.6%
- Adjusted ebitda
- 131200000
- Adjusted eps yoy
- 25.1%
- Total enrollment
- 104713
- Adjusted ebitda yoy
- 17.1%
- Term loan repricing
- $510M Term Loan B repriced to SOFR plus 2.00% (25 bps reduction)
- Share repurchases q1
- $84 million
- Adjusted ebitda margin
- 25.6%
- Free cash flow ttm q1 fy27
- 355173000
- Consecutive growth quarters
- 13
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.